A Double-Blind, Placebo-Controlled, Add-On Clinical Trial of the Safety, Pharmacokinetics and Efficacy of Lamictal in Pediatric Age Subjects (1-24 Months)
收藏DataCite Commons2026-03-18 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00000130/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
This study is being conducted to evaluate the effectiveness and safety of LAMICTAL added to the current therapy of pediatric patients age 1-24 months old with partial seizures. The medication used in this study has been approved by FDA for the adjunctive treatment of partial seizures in patients 2 years and older.
提供机构：
Vivli
创建时间：
2018-10-27
